Joint Ventures and M&A with Japanese Manufacturers

Why overseas brand owners do this at all

Most overseas brand owners do not need to acquire or partner with their Japanese OEM manufacturer. Buying on contract works for the large majority of cosmetics, food, and supplement OEM relationships. The cases where M&A or a JV becomes worth considering tend to share one of the following motivations:

• Securing production capacity.The buyer's volume forecast outgrows what the OEM manufacturer can offer alongside its other customers.
• Locking in formulation exclusivity. The buyer cannot achieve the exclusivity it needs through a contract alone, but can achieve it through equity.
• Acquiring R&D capability.The target's formulation know-how, raw-material relationships, or applied research are themselves the asset.
• Vertical integration of distribution.Combining manufacturing with the buyer's own distribution rights in target markets to shorten the value chain.

Common transaction structures

Share acquisition

Buyer purchases 100% (or a controlling stake) of the target's shares. Simplest structure for private companies; assets and liabilities pass with the company. Suitable for clean targets with manageable historical liabilities. Requires comprehensive due diligence because historical liabilities follow the target.

Asset acquisition

Buyer purchases specific assets (manufacturing line, IP, employee contracts) rather than shares. Useful when historical liabilities are a concern, or when the target operates multiple businesses and only one is in scope. Adds employment transfer complexity under Japanese labour law — employee transfers require employee consent, not automatic transfer.

Joint venture (JV)

New entity (NewCo) jointly owned by the overseas brand and the Japanese manufacturer, or minority equity stake in the existing manufacturer. Useful when the manufacturer is unwilling to sell outright or when the deal economics work better with shared ownership. Requires careful drafting of governance, deadlock, exit, and IP licensing provisions.

Share-for-share exchange (株式交換)

Used when the buyer is a listed Japanese company and the target is also Japanese. The Companies Act provides specific procedures. Rare for overseas acquirers because the buyer is not Japanese, but relevant when the overseas buyer first establishes a Japanese holding company.

FEFTA review of the foreign-investment side

Acquisition of a Japanese company by a foreign acquirer is foreign direct investment under FEFTA. Most consumer-brand OEM targets fall into the ex post notification category — filing within 45 days after closing. Sensitive sectors require ex ante notification with a 30-day standstill (extendable to 5 months). The list of designated sectors is updated periodically; cosmetics, food, and supplement OEM are not typically on it, but biotech, advanced materials, and certain food-tech adjacencies can be.

Confirm sector classification with Japanese counsel before signing the SPA, not after. An ex ante filing requirement discovered at signing pushes the closing date by 1–5 months.

JFTC merger filing

The Antimonopoly Act requires a pre-closing merger notification to the Japan Fair Trade Commission if the parties' combined domestic turnover exceeds statutory thresholds. The filing triggers a 30-day standstill from acceptance; the JFTC can extend review to a second phase.

For OEM-side deals, the most common antitrust concern is vertical integration with downstream brand customers — e.g. an acquired manufacturer losing its capacity to serve the buyer's competitors. Address this in the deal narrative submitted with the filing.

Deal sequencing pattern

1. NDA and initial discussions. Mutual NDA, sharing of high-level financial and operational information, agreement on outline structure.
2. Letter of intent (LOI) or term sheet. Non-binding on price and structure, binding on exclusivity and confidentiality.
3. Due diligence. Legal, financial, tax, regulatory, IP, environmental, HR. Japanese targets typically provide a data room organised by category; physical site visits to the manufacturing line are usual.
4. SPA negotiation.Representations and warranties (R&W), indemnities, conditions precedent, FEFTA and JFTC clearance carve-outs, escrow and W&I insurance (increasingly common in Japanese mid-market).
5. Signing. SPA execution; press release if appropriate; commencement of regulatory filings.
6. Regulatory clearances. FEFTA ex post or ex ante, JFTC merger filing, any sector-specific approvals (cosmetics MAH, food sanitation permits if changing ownership).
7. Closing. Funds flow, share transfer (or asset transfer), board reconstitution, change of representative director if applicable.
8. Post-closing integration.Integration of finance, HR, IT, and customer relationships; transitional services where the target's parent is the seller.

Things that look standard elsewhere and surprise overseas acquirers in Japan

• Indemnity language.Japanese R&W and indemnity provisions are typically narrower than US-market deals. W&I insurance is increasingly used to bridge the gap.
• Employee retention. Japanese employment law makes layoffs hard. Acquirers should plan for the existing workforce to continue, with reorganisation as a multi-year effort if needed.
• Cultural integration timelines. Japanese managers integrating with a non-Japanese parent typically need 12–24 months of structured integration support before information flow normalises.
• Public communication. Public announcements about the transaction are usually tightly choreographed with customers, suppliers, and employees in mind. Premature disclosure can damage customer relationships.